FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969949126> ?p ?o ?g. }

• W1969949126 endingPage "1449" @default.
• W1969949126 startingPage "1442" @default.
• W1969949126 abstract "PurposeThis study evaluated the outcomes of secondary procedures after endovascular aneurysm repair (EVAR).MethodsFrom 2002 to 2009, 1768 patients underwent EVAR for treatment of 1662 elective (94%) and 106 emergent (6%) infrarenal abdominal aortic aneurysm (AAA) with a variety of Food and Drug Administration-approved and commercially available stent grafts. Postoperative follow-up included clinical examination, pulse volume recording, duplex ultrasound imaging, and computed tomography and magnetic resonance angiography at 1, 6, and 12 months, and yearly thereafter. Patients with type I and III endoleaks, unexplained endotension, limb occlusion, stent graft migration, with and without type I endoleak, and aneurysm rupture underwent secondary interventions. Type II endoleak at >6 months without a decrease in the aneurysm sac underwent translumbar embolization. Data were prospectively collected.ResultsEVAR was performed in 1768 patients. During a mean follow-up of 34 (SD, 30.03) months, 339 patients (19.2%) required additional secondary procedures for aneurysm-related complications, including type I (n = 51, 15.0%), type II (n = 136, 40.1%), and type III (n = 5, 1.5%) endoleaks; endotension (n = 8, 2.4%), stent graft migration proximal fixation site (n = 46, 13.6%), stent graft iliac limb thrombosis or stenosis (n = 25, 7.4%), subsequent iliac aneurysm formation (n = 39, 11.5%), or aneurysm rupture after EVAR (n = 29, 8.6%). The mean age was 74 (SD, 9.15) years. Mean AAA size was 5.7 (SD 3.24) cm. Compared with secondary procedures for AAA rupture, the nonrupture patients had a significantly lower mortality (1.6% vs 17.2%, P < .05) and a higher likelihood of being managed by endovascular means (98.8% vs 44.8%, P < .05). When nonruptured EVAR patients required urgent secondary procedures for type I endoleaks and stent graft migration or limb thrombosis, the mortality was 6.0% vs 0.5% for elective procedures (P < .05).ConclusionsOur long-term EVAR experience indicates that 18% of patients require additional secondary procedures, and most of these patients can be managed by endovascular means with an acceptable overall mortality of 2.9%. Most type I and II endoleaks can be successfully treated by transluminal embolization, and most patients with delayed aneurysm rupture after EVAR can be successfully managed by endovascular or open surgical repair. This study evaluated the outcomes of secondary procedures after endovascular aneurysm repair (EVAR). From 2002 to 2009, 1768 patients underwent EVAR for treatment of 1662 elective (94%) and 106 emergent (6%) infrarenal abdominal aortic aneurysm (AAA) with a variety of Food and Drug Administration-approved and commercially available stent grafts. Postoperative follow-up included clinical examination, pulse volume recording, duplex ultrasound imaging, and computed tomography and magnetic resonance angiography at 1, 6, and 12 months, and yearly thereafter. Patients with type I and III endoleaks, unexplained endotension, limb occlusion, stent graft migration, with and without type I endoleak, and aneurysm rupture underwent secondary interventions. Type II endoleak at >6 months without a decrease in the aneurysm sac underwent translumbar embolization. Data were prospectively collected. EVAR was performed in 1768 patients. During a mean follow-up of 34 (SD, 30.03) months, 339 patients (19.2%) required additional secondary procedures for aneurysm-related complications, including type I (n = 51, 15.0%), type II (n = 136, 40.1%), and type III (n = 5, 1.5%) endoleaks; endotension (n = 8, 2.4%), stent graft migration proximal fixation site (n = 46, 13.6%), stent graft iliac limb thrombosis or stenosis (n = 25, 7.4%), subsequent iliac aneurysm formation (n = 39, 11.5%), or aneurysm rupture after EVAR (n = 29, 8.6%). The mean age was 74 (SD, 9.15) years. Mean AAA size was 5.7 (SD 3.24) cm. Compared with secondary procedures for AAA rupture, the nonrupture patients had a significantly lower mortality (1.6% vs 17.2%, P < .05) and a higher likelihood of being managed by endovascular means (98.8% vs 44.8%, P < .05). When nonruptured EVAR patients required urgent secondary procedures for type I endoleaks and stent graft migration or limb thrombosis, the mortality was 6.0% vs 0.5% for elective procedures (P < .05). Our long-term EVAR experience indicates that 18% of patients require additional secondary procedures, and most of these patients can be managed by endovascular means with an acceptable overall mortality of 2.9%. Most type I and II endoleaks can be successfully treated by transluminal embolization, and most patients with delayed aneurysm rupture after EVAR can be successfully managed by endovascular or open surgical repair." @default.
• W1969949126 created "2016-06-24" @default.
• W1969949126 creator A5016716157 @default.
• W1969949126 creator A5020926571 @default.
• W1969949126 creator A5026165065 @default.
• W1969949126 creator A5031855981 @default.
• W1969949126 creator A5032204536 @default.
• W1969949126 creator A5053848633 @default.
• W1969949126 creator A5062714293 @default.
• W1969949126 creator A5069114572 @default.
• W1969949126 date "2010-12-01" @default.
• W1969949126 modified "2023-10-16" @default.
• W1969949126 title "Long-term outcomes of secondary procedures after endovascular aneurysm repair" @default.
• W1969949126 cites W1995749852 @default.
• W1969949126 cites W2000903517 @default.
• W1969949126 cites W2021942359 @default.
• W1969949126 cites W2025656600 @default.
• W1969949126 cites W2026983715 @default.
• W1969949126 cites W2030660199 @default.
• W1969949126 cites W2039005801 @default.
• W1969949126 cites W2043303066 @default.
• W1969949126 cites W2054969445 @default.
• W1969949126 cites W2078813235 @default.
• W1969949126 cites W2095324871 @default.
• W1969949126 cites W2099201701 @default.
• W1969949126 cites W2143899953 @default.
• W1969949126 cites W2170766374 @default.
• W1969949126 doi "https://doi.org/10.1016/j.jvs.2010.06.110" @default.
• W1969949126 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20724099" @default.
• W1969949126 hasPublicationYear "2010" @default.
• W1969949126 type Work @default.
• W1969949126 sameAs 1969949126 @default.
• W1969949126 citedByCount "143" @default.
• W1969949126 countsByYear W19699491262012 @default.
• W1969949126 countsByYear W19699491262013 @default.
• W1969949126 countsByYear W19699491262014 @default.
• W1969949126 countsByYear W19699491262015 @default.
• W1969949126 countsByYear W19699491262016 @default.
• W1969949126 countsByYear W19699491262017 @default.
• W1969949126 countsByYear W19699491262018 @default.
• W1969949126 countsByYear W19699491262019 @default.
• W1969949126 countsByYear W19699491262020 @default.
• W1969949126 countsByYear W19699491262021 @default.
• W1969949126 countsByYear W19699491262022 @default.
• W1969949126 countsByYear W19699491262023 @default.
• W1969949126 crossrefType "journal-article" @default.
• W1969949126 hasAuthorship W1969949126A5016716157 @default.
• W1969949126 hasAuthorship W1969949126A5020926571 @default.
• W1969949126 hasAuthorship W1969949126A5026165065 @default.
• W1969949126 hasAuthorship W1969949126A5031855981 @default.
• W1969949126 hasAuthorship W1969949126A5032204536 @default.
• W1969949126 hasAuthorship W1969949126A5053848633 @default.
• W1969949126 hasAuthorship W1969949126A5062714293 @default.
• W1969949126 hasAuthorship W1969949126A5069114572 @default.
• W1969949126 hasBestOaLocation W19699491261 @default.
• W1969949126 hasConcept C126838900 @default.
• W1969949126 hasConcept C141071460 @default.
• W1969949126 hasConcept C2776035437 @default.
• W1969949126 hasConcept C2776098176 @default.
• W1969949126 hasConcept C2776268601 @default.
• W1969949126 hasConcept C2776543907 @default.
• W1969949126 hasConcept C2777323849 @default.
• W1969949126 hasConcept C2778583881 @default.
• W1969949126 hasConcept C2779993416 @default.
• W1969949126 hasConcept C2780643987 @default.
• W1969949126 hasConcept C2780868729 @default.
• W1969949126 hasConcept C71924100 @default.
• W1969949126 hasConceptScore W1969949126C126838900 @default.
• W1969949126 hasConceptScore W1969949126C141071460 @default.
• W1969949126 hasConceptScore W1969949126C2776035437 @default.
• W1969949126 hasConceptScore W1969949126C2776098176 @default.
• W1969949126 hasConceptScore W1969949126C2776268601 @default.
• W1969949126 hasConceptScore W1969949126C2776543907 @default.
• W1969949126 hasConceptScore W1969949126C2777323849 @default.
• W1969949126 hasConceptScore W1969949126C2778583881 @default.
• W1969949126 hasConceptScore W1969949126C2779993416 @default.
• W1969949126 hasConceptScore W1969949126C2780643987 @default.
• W1969949126 hasConceptScore W1969949126C2780868729 @default.
• W1969949126 hasConceptScore W1969949126C71924100 @default.
• W1969949126 hasIssue "6" @default.
• W1969949126 hasLocation W19699491261 @default.
• W1969949126 hasLocation W19699491262 @default.
• W1969949126 hasOpenAccess W1969949126 @default.
• W1969949126 hasPrimaryLocation W19699491261 @default.
• W1969949126 hasRelatedWork W2078170568 @default.
• W1969949126 hasRelatedWork W2186960680 @default.
• W1969949126 hasRelatedWork W2561758251 @default.
• W1969949126 hasRelatedWork W2590903494 @default.
• W1969949126 hasRelatedWork W2791524134 @default.
• W1969949126 hasRelatedWork W3036739990 @default.
• W1969949126 hasRelatedWork W3140197794 @default.
• W1969949126 hasRelatedWork W4210480356 @default.
• W1969949126 hasRelatedWork W4247657876 @default.
• W1969949126 hasRelatedWork W3014013020 @default.
• W1969949126 hasVolume "52" @default.
• W1969949126 isParatext "false" @default.
• W1969949126 isRetracted "false" @default.
• W1969949126 magId "1969949126" @default.

• next